| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 18.431 | 37.771 | 38.886 | 34.460 | 42.075 | 49.624 | 47.826 | 52.868 |
| Total Income - EUR | - | - | 18.819 | 40.468 | 38.886 | 34.460 | 54.324 | 49.624 | 48.444 | 52.868 |
| Total Expenses - EUR | - | - | 21.525 | 39.765 | 39.531 | 33.335 | 58.606 | 48.400 | 46.943 | 56.677 |
| Gross Profit/Loss - EUR | - | - | -2.706 | 703 | -646 | 1.124 | -4.282 | 1.224 | 1.501 | -3.809 |
| Net Profit/Loss - EUR | - | - | -2.873 | 325 | -1.035 | 780 | -4.825 | 733 | 1.026 | -4.330 |
| Employees | - | - | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 |
Check the financial reports for the company - Ovirox Prodcom S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 8.830 | 12.522 | 13.324 | 14.487 | 7.274 | 12.213 | 17.224 | 8.580 |
| Inventories | - | - | 5.793 | 12.432 | 13.131 | 13.349 | 6.010 | 11.075 | 15.919 | 6.598 |
| Receivables | - | - | 0 | 0 | 0 | 1.003 | 1.088 | 1.092 | 1.089 | 0 |
| Cash | - | - | 3.037 | 90 | 194 | 134 | 175 | 46 | 217 | 1.983 |
| Shareholders Funds | - | - | -2.830 | -2.453 | -3.440 | -2.595 | -7.363 | -6.653 | -5.607 | -9.905 |
| Social Capital | - | - | 44 | 43 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debts | - | - | 11.659 | 14.975 | 16.764 | 17.082 | 14.636 | 18.865 | 22.830 | 18.485 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1071 - 1071" | |||||||||
| CAEN Financial Year |
1071
|
|||||||||
Comments - Ovirox Prodcom S.r.l.